These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20002155)

  • 1. Diagnostic challenges and recent advances in the early management of invasive fungal infections.
    Chandrasekar P
    Eur J Haematol; 2010 Apr; 84(4):281-90. PubMed ID: 20002155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive mycoses: diagnostic challenges.
    Ostrosky-Zeichner L
    Am J Med; 2012 Jan; 125(1 Suppl):S14-24. PubMed ID: 22196205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances and challenges in the treatment of invasive fungal infections.
    Shao PL; Huang LM; Hsueh PR
    Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive fungal infection--laboratory diagnosis and antifungal treatment.
    Shao PL; Huang LM; Hsueh PR
    J Microbiol Immunol Infect; 2006 Jun; 39(3):178-88. PubMed ID: 16783447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of new diagnostic approaches to antifungal treatment plans in high-risk haematology patients.
    Einsele H; Loeffler J
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():37-45. PubMed ID: 18430128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular and immunological methods applied in diagnosis of mycoses].
    Kuba K
    Wiad Parazytol; 2008; 54(3):187-97. PubMed ID: 19055059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fungal infections in ICU patients: epidemiology and the role of diagnostics.
    Morace G; Borghi E
    Minerva Anestesiol; 2010 Nov; 76(11):950-6. PubMed ID: 21102391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The rationale of combination antifungal therapy in severely immunocompromised patients: empiricism versus evidence-based medicine.
    Chamilos G; Kontoyiannis DP
    Curr Opin Infect Dis; 2006 Aug; 19(4):380-5. PubMed ID: 16804387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early diagnosis of invasive fungal infections in hematooncological patients by serological methods].
    Rácil Z; Kocmanová I; Wagnerová B; Lengerová M; Mayer J
    Vnitr Lek; 2007 Sep; 53(9):990-9. PubMed ID: 18019671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of histopathological analysis, culture, and polymerase chain reaction assays to detect invasive mold infections from biopsy specimens.
    Rickerts V; Mousset S; Lambrecht E; Tintelnot K; Schwerdtfeger R; Presterl E; Jacobi V; Just-Nübling G; Bialek R
    Clin Infect Dis; 2007 Apr; 44(8):1078-83. PubMed ID: 17366453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal infections in the immunocompromised host.
    Hawkins C; Armstrong D
    Clin Haematol; 1984 Oct; 13(3):599-630. PubMed ID: 6388935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in antifungal prevention and treatment.
    Groll AH; Tragiannidis A
    Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation and management of fungal infections in immunocompromised patients.
    Venkatesan P; Perfect JR; Myers SA
    Dermatol Ther; 2005; 18(1):44-57. PubMed ID: 15842612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical overview of clinical guidelines relating to invasive fungal infections.
    Sá MB; Zaragoza R
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S155-9. PubMed ID: 19013341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in invasive fungal infections, with emphasis on invasive aspergillosis.
    Erjavec Z; Kluin-Nelemans H; Verweij PE
    Clin Microbiol Infect; 2009 Jul; 15(7):625-33. PubMed ID: 19673973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
    Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
    Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current challenges in the management of invasive fungal infections.
    Lai CC; Tan CK; Huang YT; Shao PL; Hsueh PR
    J Infect Chemother; 2008 Apr; 14(2):77-85. PubMed ID: 18622668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.